<VariationArchive VariationID="643407" VariationName="NM_003238.6(TGFB2):c.990dup (p.Gly331fs)" VariationType="Duplication" Accession="VCV000643407" Version="11" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2019-08-14" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="627375" VariationID="643407">
      <GeneList>
        <Gene Symbol="TGFB2" FullName="transforming growth factor beta 2" GeneID="7042" HGNC_ID="HGNC:11768" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q41</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="218345336" stop="218444619" display_start="218345336" display_stop="218444619" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="218518675" stop="218617960" display_start="218518675" display_stop="218617960" Strand="+" />
          </Location>
          <OMIM>190220</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003238.6(TGFB2):c.990dup (p.Gly331fs)</Name>
      <CanonicalSPDI>NC_000001.11:218437399:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1q41</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="218437399" stop="218437400" display_start="218437399" display_stop="218437400" variantLength="1" positionVCF="218437399" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="218610741" stop="218610742" display_start="218610741" display_stop="218610742" variantLength="1" positionVCF="218610741" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
      </Location>
      <ProteinChange>G331fs</ProteinChange>
      <ProteinChange>G359fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003238.3" sequenceAccession="NM_003238" sequenceVersion="3" change="c.990dup">
            <Expression>NM_003238.3:c.990dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.218610742dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.218610742dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.218437400dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.218437400dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_027721.2" sequenceAccession="NG_027721" sequenceVersion="2" change="g.97067dup">
            <Expression>NG_027721.2:g.97067dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001135599.4" sequenceAccession="NM_001135599" sequenceVersion="4" change="c.1074dup">
            <Expression>NM_001135599.4:c.1074dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001129071.1" sequenceAccession="NP_001129071" sequenceVersion="1" change="p.Gly359fs">
            <Expression>NP_001129071.1:p.Gly359fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003238.6" sequenceAccession="NM_003238" sequenceVersion="6" change="c.990dup" MANESelect="true">
            <Expression>NM_003238.6:c.990dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003229.1" sequenceAccession="NP_003229" sequenceVersion="1" change="p.Gly331fs">
            <Expression>NP_003229.1:p.Gly331fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_138148.2" sequenceAccession="NR_138148" sequenceVersion="2" change="n.2241dup">
            <Expression>NR_138148.2:n.2241dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_138149.2" sequenceAccession="NR_138149" sequenceVersion="2" change="n.2325dup">
            <Expression>NR_138149.2:n.2325dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1571904218" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003238.6(TGFB2):c.990dup (p.Gly331fs) AND Loeys-Dietz syndrome 4" Accession="RCV001824373" Version="14">
        <ClassifiedConditionList TraitSetID="8852">
          <ClassifiedCondition DB="MedGen" ID="C3553762">Loeys-Dietz syndrome 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-02-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-02-18" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-08-14" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22772368</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8852" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17363" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ANEURYSM, AORTIC AND CEREBRAL, WITH ARTERIAL TORTUOSITY AND SKELETAL MANIFESTATIONS</ElementValue>
                <XRef Type="MIM" ID="614816" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Loeys-Dietz syndrome 4</ElementValue>
                <XRef ID="MONDO:0013897" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LDS4</ElementValue>
                <XRef Type="MIM" ID="614816" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Loeys-Dietz syndrome (LDS) is characterized by vascular findings (cerebral, thoracic, and abdominal arterial aneurysms and/or dissections), skeletal manifestations (pectus excavatum or pectus carinatum, scoliosis, joint laxity, arachnodactyly, talipes equinovarus, cervical spine malformation and/or instability), craniofacial features (widely spaced eyes, strabismus, bifid uvula / cleft palate, and craniosynostosis that can involve any sutures), and cutaneous findings (velvety and translucent skin, easy bruising, and dystrophic scars). Individuals with LDS are predisposed to widespread and aggressive arterial aneurysms and pregnancy-related complications including uterine rupture and death. Individuals with LDS can show a strong predisposition for allergic/inflammatory disease including asthma, eczema, and reactions to food or environmental allergens. There is also an increased incidence of gastrointestinal inflammation including eosinophilic esophagitis and gastritis or inflammatory bowel disease. Wide variation in the distribution and severity of clinical features can be seen in individuals with LDS, even among affected individuals within a family who have the same pathogenic variant.</Attribute>
                <XRef ID="NBK1133" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10588" />
                <XRef ID="10588" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301312</ID>
                <ID Source="BookShelf">NBK1133</ID>
              </Citation>
              <XRef ID="C3553762" DB="MedGen" />
              <XRef ID="MONDO:0013897" DB="MONDO" />
              <XRef Type="MIM" ID="614816" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1830488" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="5609846|MedGen:C3553762" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000936638" DateUpdated="2024-02-20" DateCreated="2019-08-14" Type="SCV" Version="7" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-02-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22772368</ID>
          </Citation>
          <Comment>Experimental studies and prediction algorithms are not available for this variant, and the functional significance of the affected amino acid(s) is currently unknown. This variant has not been reported in the literature in individuals with TGFB2-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change results in a premature translational stop signal in the TGFB2 gene (p.Gly331Argfs*38). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 84 amino acids of the TGFB2 protein. This variant disrupts the C-terminus of the TGFB2 protein. Other variant(s) that disrupt this region (p.Tyr341Cysfs*26, also known as p.Tyr369Cysfs*26) have been determined to be pathogenic (PMID: 22772368). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TGFB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.218610741_218610742insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3553762" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11050867</SubmissionName>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1830488" TraitType="Disease" MappingType="XRef" MappingValue="C3553762" MappingRef="MedGen">
        <MedGen CUI="C3553762" Name="Loeys-Dietz syndrome 4" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

